Biological basis of the HLA-B8,DR3-associated progression of acquired immune deficiency syndrome

Pathobiology

Volumn 66, Issue 1, 1998, Pages 33-37

  Candore, Giuseppina ^a   Romano, Guiseppina Colonna ^a   D'Anna, Claudia ^a   Di Lorenzo, Gabriele ^a   Gervasi, Francesco ^b   Lio, Domenico ^a   Modica, Maria Assunta ^a   Potestio, Marcella ^a   Caruso, Calogero ^a,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b G Di Cristina e M Ascoli   (Italy)

^c Servizio di Tipizzazione Tissutale   (Italy)

Author keywords

AIDS; Cytokines, type 1; Cytokines, type 2; HLA B8,DR3; Th1 cells; Th2 cells

Indexed keywords

CYTOKINE; HLA B ANTIGEN; HLA DR3 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; AUTOIMMUNITY; CAUCASIAN; DISEASE COURSE; GENOTYPE; HAPLOTYPE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; GENOTYPE; HAPLOTYPES; HLA-B8 ANTIGEN; HLA-DR3 ANTIGEN; HUMANS; TH2 CELLS;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0031937464     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027992     Document Type: Article

References (44)

1. Nepom GT: The effects of variations in human immune-response genes. N Engl J Med 1989; 321:751-752.
2. Mann DL, Murray C, Yarchoan R, Blattner WA, Goedert JJ: HLA antigen frequencies in HIV-1 seropositive disease free individuals and patients with AIDS: J AIDS 1988;1:13-18.
3. Louie LG, Newman B, King M-C: Influence of host genotype on progression to AIDS among HIV infected men. J AIDS 1991;4:814-818.
4. Raffoux C, David V, Cuderc LD, Rabion C, Clauvel JP, Seligmann M, Colombani J: HLA-A. B and DR antigen frequencies in patients with AIDS-related persistent generalized lymphoadenopathy (PGL) and thrombocytopenia. Tissue Antigens 1987;29:60-62.
5. Odum N, Georgsen J, Fugger L, Moller J, Jakobsen BK, Hofmann B, Skinhoj P, Klokker M, Dickmeiss E, Swejgaard A: HLA-DP antigens in HIV-infected individuals. Dis Markers 1990;8:113-116
6. Donald JA, Rudman K, Cooper DW: Baumgart KW, Garsia RJ, Garenby PA, Rickard KA: Progression of HIV related disease is associated with HLA DQ and DR alleles defined by restriction length polymorphisms. Tissue Antigens 1992;39.241-248
7. Choppin J, Martinon F, Gomard E, Bahraoui E, Connon F, Bauillot M, Levy JP, Analysis of physical interactions between peptides and HLA molecules and application to the detection of immunodeficiency virus 1 antigenic peptides. J Exp Med 1990;172:889-899.
8. Young Jt HIV and HLA similarity (letter). Nature 1988;333:215.
9. Kion TA, Hoffman GW: Anti HIV and anti-anti HLA antibodies in alloimmune and in autoimmune mice. Science 1991;253:1138-1143.
10. Just JJ: Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome. A review of the literature examining associations with HLA. Hum Immunol 1995; 44:156-169.
11. Alper CA: The human immune response to hepatitis B surface antigen. Exp Clin Immunogenet 1995;12:171-181.
12. Degli-Esposti MA, Leelayuwat C, Daly LN, Carcassi C, Contu L, Versluis LF, Tilanus MCJ, Dawkins RL: Updated characterization of the fourth ancestral haplotypes using Asia-Oceania histocompatibility workshop panel. Hum Immunol 1995;44:12-18.
13. Steel CM, Ludlam CA: Beatson D, Peutherer JF, Cuthbert RJG, Simmonds P, Morrison H, Jones M: HLA haplotype A1 B8 D3 as a risk factor for HIV-related disease. Lancet 1988; 333:1185-1188.
14. Kaslow RA, Duquesnoy R, VanRaden M, Kingsley L, Marrari M, Friedman H, Su S, Saah AJ, Detels R, Phair J, Rinaldo C: A1,Cw7,B8,DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet 1990;335: 927-930.
15. Kaplan C, Muller JY, Doinel C, Lefrère JJ, Paquez F, Rouger P, Salmon D, Salmon C: HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-1-seropositive subjects. Hum Hered 1990;40:290-297.
16. Cameron PU, Mallal SA, French MAH, Dawkins RL: Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol 1990;29:282-295.
17. Modica MA, Colucci AT, Candore G, Caruso C: The HLA-B8,DR3 haplotype and immune response in healthy subjects. Immunol Inf Dis 1993;3:119-127.
18. Caruso C, Candore G, Modica MA, Bonanno CT, Sireci G, Dieli F, Salerno A: Major histocompatibility complex regulation of cytokine production. J Interferon Cytokine Res 1996; 16:983-988.
19. Westby M, Manca F, Dalgleish AG: The role of host immune responses in determining the outcome of HIV infection. Immunol Today 1996; 17:120-126.
20. Dalgleish AG: The immune response to HIV: Potential for immunotherapy? Immunol Today 1995;16.356-358.
21. Clerici M, Shearer GM: The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-581.
22. Clerici M, Shearer GM: A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
23. Kinter A, Fauci AS: Interleukin-2 and human immunodeficiency virus infection. Pathogenic mechanisms and potential for immunologic enhancement. Immunol Res 1996;15:1-15.
24. Shearer GM, Clerici M: Protective immunity against HIV infection: Has nature done the experiment for us? Immunol Today 1996;17: 21-24.
25. Romagnani S: Biology of human Th1 and Th2 cells. J Clin Immunol 1995;15:121-129.
26. Haanen JBAG, De Waal Maleflijt R, Res PCM, Kraakman EM, Ottenhoff THM, De Vries RRP, Spits H: Selection of a human T helper type-1 like T cell subset by mycobacteria. J Exp Med 1991;174:583-592.
27. Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, Ivanyi J: Th1/ Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-176.
28. Kemp M, Theander TG, Kharazmi A: The contrasting roles of CD4+ T cells in intracellular infections in humans: Leishmaniasis as an example. Immunol Today 1996;17:13-16.
29. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of Th1 and Th2 cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1996;6:1545-1550.
30. Romagnani S, Maggi E, Del Prete G: HIV can induce a Th1 to Th2 shift and preferentially replicates in CD4+ T-cell clones producing Th2 type cytokines. Res Immunol 1994;145:611-618.
31. Grinspoon SK, Bilezikian JP: HIV disease and the endocrine system. N Engl J Med 1992;327: 1360-1365.
32. Clerici M, Bevilacqua M, Vago T, Villa ML, Shearer GM, Norbiato G: An immunoendocrinologic hypothesis for HIV infection. Lancet 1994;343:1552-1553.
33. Modica MA, Cammarata G, Caruso C: HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin. J Immunogenet 1990; 17:101-107.
34. Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C: In vitro cytokine production by HLA-B8,DR3 positive subjects. Autoimmunity 1994;18:121-132.
35. Lio D, D'Anna C, Gervasi F, Cigna D, Modica MA, Candore G, Caruso C: In vitro impairment of interleukin-5 production in HLA-B8,DR3-positive individuals. Implications for immunoglobulin A synthesis dysfunction. Hum Immunol 1995;44:170-174.
36. Candore G, Colombo A, Colonna Romano G, D'Anna C, Di Lorenzo G, Gervasi F, Iona P, Lio D, Lucania G, Modica MA, Potestio M, Caruso C: In vitro dissociated production of IL-10 and IL-12 by mononuclear cells (MNC) from HLA-B8,DR3 positive individuals (abstract). Proc II Roche Symposium. Milan. 1996, p 185.
37. Caruso C, Candore G, Cigna D, Di Lorenzo G, Gervasi F, Lucania G, Modica MA, Potestio M, Colonna Romano G: Lymphocyte blood levels are affected by HLA-B8,DR3 haplotype (abstract). Hum Immunol 1996;47:37.
38. Caruso C, Bongiardina C, Candore G, Cigna D, Colonna Romano G, Colucci AT, Di Lorenzo G, Gervasi F, Manno M, Potestio M, Tantillo G: HLA-B8,DR3 haplotype affects lymphocyte blood levels. Immunol Invest 1997;26:333-340.
39. Colonna Romano G, Gervasi F, Potestio M, Candore G, D'Anna C, Balistreri CR, Di Lorenzo G, Modica MA, Lio D, Caruso C: Increased serum levels of TNF-α and cortisol in HLA-B8,DR3 positive subjects (abstract). Eur J Immunogenet 1997;24:PS-153.
40. D'Alfonso S, Momigliano Richiardi PA. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994;30:150-154.
41. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. JAMA 1992;267: 1244-1252.
42. Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246-1253.
43. Gerencer M, Tajic M, Kerhin-Brkljacic V, Kastelan A: An association between serum testosterone level and HLA phenotype. Immunol Lett 1982;4:155-156.
44. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.